VBIO
Valion Bio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.73M
P/E Ratio
—
EPS
$-6.66
Beta
1.87
52W High
$5.60
52W Low
$0.72
50-Day MA
$1.00
200-Day MA
$1.83
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Valion Bio Inc
Vitality Biopharma, Inc. focuses on developing cannabinoid pharmaceutical prodrugs in the United States. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-7.89M |
| Operating Margin | 0.00% |
| Return on Equity | -82.70% |
| Return on Assets | -28.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.65 |
| Price-to-Book | 0.25 |
| Price-to-Sales (TTM) | 1.52 |
| EV/Revenue | 0.563 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.20M |
| Float | $2.76M |
| % Insiders | 1.34% |
| % Institutions | 10.52% |
Historical Volatility
HV 10-Day
119.75%
HV 20-Day
155.89%
HV 30-Day
152.71%
HV 60-Day
127.85%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/25/2026